David W. Dube
President at Stock Car Stocks Mutual Fund, Inc.
David W. Dube active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Stock Car Stocks Mutual Fund, Inc. | President | 2009-12-22 | - |
Career history of David W. Dube
Former positions of David W. Dube
| Companies | Position | Start | End |
|---|---|---|---|
| CNE Group, Inc. | Director/Board Member | - | 2005-11-13 |
| SWAN GROUP OF COMPANIES, INC. | Chairman | - | - |
| Director of Finance/CFO | - | - | |
Glycogenesys, Inc.
 Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | Director/Board Member | 1998-04-30 | - |
| Independent Dir/Board Member | 1998-04-30 | - |
Training of David W. Dube
| Suffolk University | Graduate Degree |
| Bentley University | Graduate Degree |
Statistics
International
| United States | 7 |
Operational
| Director/Board Member | 2 |
| Graduate Degree | 2 |
| Independent Dir/Board Member | 1 |
Sectoral
| Commercial Services | 3 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
| CNE Group, Inc. | Commercial Services |
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | Commercial Services |
| Stock Car Stocks Mutual Fund, Inc. | Miscellaneous |
Swan Group of Cos., Inc.
 Swan Group of Cos., Inc. Wholesale DistributorsDistribution Services Swan Group of Companies, Inc. engages in the manufacture and sale of smokeless cigarette products. The company was founded on January 24, 1996 and is headquartered in Largo, FL. | Distribution Services |
- Stock Market
- Insiders
- David W. Dube
- Experience
